Global Functional Dyspepsia Drug Market Growth 2020-2025
According to this study, over the next five years the Functional Dyspepsia Drug market will register a 2.9%% CAGR in terms of revenue, the global market size will reach $ 6308.1 million by 2025, from $ 5623.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Functional Dyspepsia Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Functional Dyspepsia Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Functional Dyspepsia Drug, covering the supply chain analysis, impact assessment to the Functional Dyspepsia Drug market size growth rate in several scenarios, and the measures to be undertaken by Functional Dyspepsia Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
The classification of Functional Dyspepsia Drug includes Prokinetic Drugs, Gastric Antisecretory Drugs, etc. The proportion of Gastric Antisecretory Drugs in 2019 is about 47.86%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Drugstores
The application of Functional Dyspepsia Drug includes hospitals and drugstores. The proportion of hospitals in 2019 is about 63.85%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Eisai
Sumitomo
Teva
Johnson & Johnson
Cadila Pharmaceuticals
AstraZeneca
Pfizer
Jiangsu Aosaikang Pharma
Sanofi
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Functional Dyspepsia Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Functional Dyspepsia Drug market by identifying its various subsegments.
Focuses on the key global Functional Dyspepsia Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Functional Dyspepsia Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Functional Dyspepsia Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Functional Dyspepsia Drug Consumption 2015-2025
2.1.2 Functional Dyspepsia Drug Consumption CAGR by Region
2.2 Functional Dyspepsia Drug Segment by Type
2.2.1 Prokinetic Drugs
2.2.2 Gastric Antisecretory Drugs
2.2.3 Others
2.3 Functional Dyspepsia Drug Consumption by Type
2.3.1 Global Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Functional Dyspepsia Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Functional Dyspepsia Drug Sale Price by Type (2015-2020)
2.4 Functional Dyspepsia Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.5 Functional Dyspepsia Drug Consumption by Application
2.5.1 Global Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Functional Dyspepsia Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Functional Dyspepsia Drug Sale Price by Type (2015-2020)
3 Global Functional Dyspepsia Drug by Company
3.1 Global Functional Dyspepsia Drug Sales Market Share by Company
3.1.1 Global Functional Dyspepsia Drug Sales by Company (2018-2020)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Company (2018-2020)
3.2 Global Functional Dyspepsia Drug Revenue Market Share by Company
3.2.1 Global Functional Dyspepsia Drug Revenue by Company (2018-2020)
3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Company (2018-2020)
3.3 Global Functional Dyspepsia Drug Sale Price by Company
3.4 Global Functional Dyspepsia Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Functional Dyspepsia Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Functional Dyspepsia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Functional Dyspepsia Drug by Regions
4.1 Functional Dyspepsia Drug by Regions
4.2 Americas Functional Dyspepsia Drug Consumption Growth
4.3 APAC Functional Dyspepsia Drug Consumption Growth
4.4 Europe Functional Dyspepsia Drug Consumption Growth
4.5 Middle East & Africa Functional Dyspepsia Drug Consumption Growth
5 Americas
5.1 Americas Functional Dyspepsia Drug Consumption by Countries
5.1.1 Americas Functional Dyspepsia Drug Consumption by Countries (2015-2020)
5.1.2 Americas Functional Dyspepsia Drug Value by Countries (2015-2020)
5.2 Americas Functional Dyspepsia Drug Consumption by Type
5.3 Americas Functional Dyspepsia Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Functional Dyspepsia Drug Consumption by Regions
6.1.1 APAC Functional Dyspepsia Drug Consumption by Regions (2015-2020)
6.1.2 APAC Functional Dyspepsia Drug Value by Regions (2015-2020)
6.2 APAC Functional Dyspepsia Drug Consumption by Type
6.3 APAC Functional Dyspepsia Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Functional Dyspepsia Drug by Countries
7.1.1 Europe Functional Dyspepsia Drug Consumption by Countries (2015-2020)
7.1.2 Europe Functional Dyspepsia Drug Value by Countries (2015-2020)
7.2 Europe Functional Dyspepsia Drug Consumption by Type
7.3 Europe Functional Dyspepsia Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Functional Dyspepsia Drug by Countries
8.1.1 Middle East & Africa Functional Dyspepsia Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Functional Dyspepsia Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Functional Dyspepsia Drug Consumption by Type
8.3 Middle East & Africa Functional Dyspepsia Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Functional Dyspepsia Drug Distributors
10.3 Functional Dyspepsia Drug Customer
11 Global Functional Dyspepsia Drug Market Forecast
11.1 Global Functional Dyspepsia Drug Consumption Forecast (2021-2025)
11.2 Global Functional Dyspepsia Drug Forecast by Regions
11.2.1 Global Functional Dyspepsia Drug Forecast by Regions (2021-2025)
11.2.2 Global Functional Dyspepsia Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Functional Dyspepsia Drug Forecast by Type
11.8 Global Functional Dyspepsia Drug Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Information
12.1.2 Functional Dyspepsia Drug Product Offered
12.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Eisai
12.2.1 Company Information
12.2.2 Functional Dyspepsia Drug Product Offered
12.2.3 Eisai Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Eisai Latest Developments
12.3 Sumitomo
12.3.1 Company Information
12.3.2 Functional Dyspepsia Drug Product Offered
12.3.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sumitomo Latest Developments
12.4 Teva
12.4.1 Company Information
12.4.2 Functional Dyspepsia Drug Product Offered
12.4.3 Teva Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Teva Latest Developments
12.5 Johnson & Johnson
12.5.1 Company Information
12.5.2 Functional Dyspepsia Drug Product Offered
12.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Cadila Pharmaceuticals
12.6.1 Company Information
12.6.2 Functional Dyspepsia Drug Product Offered
12.6.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Cadila Pharmaceuticals Latest Developments
12.7 AstraZeneca
12.7.1 Company Information
12.7.2 Functional Dyspepsia Drug Product Offered
12.7.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 AstraZeneca Latest Developments
12.8 Pfizer
12.8.1 Company Information
12.8.2 Functional Dyspepsia Drug Product Offered
12.8.3 Pfizer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Jiangsu Aosaikang Pharma
12.9.1 Company Information
12.9.2 Functional Dyspepsia Drug Product Offered
12.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Jiangsu Aosaikang Pharma Latest Developments
12.10 Sanofi
12.10.1 Company Information
12.10.2 Functional Dyspepsia Drug Product Offered
12.10.3 Sanofi Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sanofi Latest Developments
12.11 Kyowa Kirin Pharmaceuticals
12.11.1 Company Information
12.11.2 Functional Dyspepsia Drug Product Offered
12.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Kyowa Kirin Pharmaceuticals Latest Developments
12.12 Hanmi Pharm
12.12.1 Company Information
12.12.2 Functional Dyspepsia Drug Product Offered
12.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Hanmi Pharm Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Functional Dyspepsia Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Prokinetic Drugs
Table 5. Major Players of Gastric Antisecretory Drugs
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Functional Dyspepsia Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Functional Dyspepsia Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Functional Dyspepsia Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Functional Dyspepsia Drug Value by Application (2015-2020)
Table 15. Global Functional Dyspepsia Drug Value Market Share by Application (2015-2020)
Table 16. Global Functional Dyspepsia Drug Sale Price by Application (2015-2020)
Table 17. Global Functional Dyspepsia Drug Sales by Company (2017-2019) (M Units)
Table 18. Global Functional Dyspepsia Drug Sales Market Share by Company (2017-2019)
Table 19. Global Functional Dyspepsia Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Functional Dyspepsia Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Functional Dyspepsia Drug Sale Price by Company (2017-2019)
Table 22. Global Functional Dyspepsia Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Functional Dyspepsia Drug Products Offered
Table 24. Functional Dyspepsia Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Functional Dyspepsia Drug Consumption by Regions 2015-2020 (M Units)
Table 26. Global Functional Dyspepsia Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Functional Dyspepsia Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Functional Dyspepsia Drug Value Market Share by Regions 2015-2020
Table 29. Americas Functional Dyspepsia Drug Consumption by Countries (2015-2020) (M Units)
Table 30. Americas Functional Dyspepsia Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Functional Dyspepsia Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Functional Dyspepsia Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Functional Dyspepsia Drug Consumption by Type (2015-2020) (M Units)
Table 34. Americas Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Functional Dyspepsia Drug Consumption by Application (2015-2020) (M Units)
Table 36. Americas Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Functional Dyspepsia Drug Consumption by Countries (2015-2020) (M Units)
Table 38. APAC Functional Dyspepsia Drug Consumption Market Share by Countries (2015-2020)
Table 39. APAC Functional Dyspepsia Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Functional Dyspepsia Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Functional Dyspepsia Drug Consumption by Type (2015-2020) (M Units)
Table 42. APAC Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Functional Dyspepsia Drug Consumption by Application (2015-2020) (M Units)
Table 44. APAC Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Functional Dyspepsia Drug Consumption by Countries (2015-2020) (M Units)
Table 46. Europe Functional Dyspepsia Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Functional Dyspepsia Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Functional Dyspepsia Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Functional Dyspepsia Drug Consumption by Type (2015-2020) (M Units)
Table 50. Europe Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Functional Dyspepsia Drug Consumption by Application (2015-2020) (M Units)
Table 52. Europe Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Functional Dyspepsia Drug Consumption by Countries (2015-2020) (M Units)
Table 54. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Functional Dyspepsia Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Functional Dyspepsia Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Functional Dyspepsia Drug Consumption by Type (2015-2020) (M Units)
Table 58. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Functional Dyspepsia Drug Consumption by Application (2015-2020) (M Units)
Table 60. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Table 61. Functional Dyspepsia Drug Distributors List
Table 62. Functional Dyspepsia Drug Customer List
Table 63. Global Functional Dyspepsia Drug Consumption Forecast by Countries (2021-2025) (M Units)
Table 64. Global Functional Dyspepsia Drug Consumption Market Forecast by Regions
Table 65. Global Functional Dyspepsia Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Functional Dyspepsia Drug Value Market Share Forecast by Regions
Table 67. Global Functional Dyspepsia Drug Consumption Forecast by Type (2021-2025) (M Units)
Table 68. Global Functional Dyspepsia Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Functional Dyspepsia Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Functional Dyspepsia Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Functional Dyspepsia Drug Consumption Forecast by Application (2021-2025) (M Units)
Table 72. Global Functional Dyspepsia Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Functional Dyspepsia Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Functional Dyspepsia Drug Value Market Share Forecast by Application (2021-2025)
Table 75. Bayer Product Offered
Table 76. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Bayer Main Business
Table 78. Bayer Latest Developments
Table 79. Bayer Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Eisai Product Offered
Table 81. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Eisai Main Business
Table 83. Eisai Latest Developments
Table 84. Eisai Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Sumitomo Product Offered
Table 86. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Sumitomo Main Business
Table 88. Sumitomo Latest Developments
Table 89. Sumitomo Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Product Offered
Table 91. Teva Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Teva Main Business
Table 93. Teva Latest Developments
Table 94. Teva Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson & Johnson Product Offered
Table 96. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Johnson & Johnson Main Business
Table 98. Johnson & Johnson Latest Developments
Table 99. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Cadila Pharmaceuticals Product Offered
Table 101. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Cadila Pharmaceuticals Main Business
Table 103. Cadila Pharmaceuticals Latest Developments
Table 104. Cadila Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. AstraZeneca Product Offered
Table 106. AstraZeneca Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Main Business
Table 108. AstraZeneca Latest Developments
Table 109. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Pfizer Product Offered
Table 111. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Pfizer Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Jiangsu Aosaikang Pharma Product Offered
Table 116. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. Jiangsu Aosaikang Pharma Main Business
Table 118. Jiangsu Aosaikang Pharma Latest Developments
Table 119. Jiangsu Aosaikang Pharma Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Sanofi Product Offered
Table 121. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. Sanofi Main Business
Table 123. Sanofi Latest Developments
Table 124. Sanofi Basic Information, Company Total Revenue (in $ million), Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Kyowa Kirin Pharmaceuticals Product Offered
Table 126. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Kyowa Kirin Pharmaceuticals Main Business
Table 128. Kyowa Kirin Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Kyowa Kirin Pharmaceuticals Latest Developments
Table 130. Hanmi Pharm Product Offered
Table 131. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 132. Hanmi Pharm Main Business
Table 133. Hanmi Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Hanmi Pharm Latest Developments
List of Figures
Figure 1. Picture of Functional Dyspepsia Drug
Figure 2. Functional Dyspepsia Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Functional Dyspepsia Drug Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Functional Dyspepsia Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Prokinetic Drugs
Figure 7. Product Picture of Gastric Antisecretory Drugs
Figure 8. Product Picture of Others
Figure 9. Global Functional Dyspepsia Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Functional Dyspepsia Drug Value Market Share by Type (2015-2020)
Figure 11. Functional Dyspepsia Drug Consumed in Hospitals
Figure 12. Global Functional Dyspepsia Drug Market: Hospitals (2015-2020) (M Units)
Figure 13. Global Functional Dyspepsia Drug Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Functional Dyspepsia Drug Consumed in Drugstores
Figure 15. Global Functional Dyspepsia Drug Market: Drugstores (2015-2020) (M Units)
Figure 16. Global Functional Dyspepsia Drug Market: Drugstores (2015-2020) ($ Millions)
Figure 17. Global Functional Dyspepsia Drug Consumption Market Share by Application (2015-2020)
Figure 18. Global Functional Dyspepsia Drug Value Market Share by Application (2015-2020)
Figure 19. Global Functional Dyspepsia Drug Sales Market Share by Company in 2017
Figure 20. Global Functional Dyspepsia Drug Sales Market Share by Company in 2019
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share by Company in 2017
Figure 22. Global Functional Dyspepsia Drug Revenue Market Share by Company in 2019
Figure 23. Global Functional Dyspepsia Drug Sale Price by Company in 2019
Figure 24. Global Functional Dyspepsia Drug Consumption Market Share by Regions 2015-2020
Figure 25. Global Functional Dyspepsia Drug Value Market Share by Regions 2015-2020
Figure 26. Americas Functional Dyspepsia Drug Consumption 2015-2020 (M Units)
Figure 27. Americas Functional Dyspepsia Drug Value 2015-2020 ($ Millions)
Figure 28. APAC Functional Dyspepsia Drug Consumption 2015-2020 (M Units)
Figure 29. APAC Functional Dyspepsia Drug Value 2015-2020 ($ Millions)
Figure 30. Europe Functional Dyspepsia Drug Consumption 2015-2020 (M Units)
Figure 31. Europe Functional Dyspepsia Drug Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Functional Dyspepsia Drug Consumption 2015-2020 (M Units)
Figure 33. Middle East & Africa Functional Dyspepsia Drug Value 2015-2020 ($ Millions)
Figure 34. Americas Functional Dyspepsia Drug Consumption Market Share by Countries in 2019
Figure 35. Americas Functional Dyspepsia Drug Value Market Share by Countries in 2019
Figure 36. Americas Functional Dyspepsia Drug Consumption Market Share by Type in 2019
Figure 37. Americas Functional Dyspepsia Drug Consumption Market Share by Application in 2019
Figure 38. United States Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 39. United States Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 41. Canada Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 43. Mexico Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Functional Dyspepsia Drug Consumption Market Share by Countries in 2019
Figure 45. APAC Functional Dyspepsia Drug Value Market Share by Regions in 2019
Figure 46. APAC Functional Dyspepsia Drug Consumption Market Share by Type in 2019
Figure 47. APAC Functional Dyspepsia Drug Consumption Market Share by Application in 2019
Figure 48. China Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 49. China Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 51. Japan Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 53. Korea Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 55. Southeast Asia Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 56. India Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 57. India Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 59. Australia Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Functional Dyspepsia Drug Consumption Market Share by Countries in 2019
Figure 61. Europe Functional Dyspepsia Drug Value Market Share by Countries in 2019
Figure 62. Europe Functional Dyspepsia Drug Consumption Market Share by Type in 2019
Figure 63. Europe Functional Dyspepsia Drug Consumption Market Share by Application in 2019
Figure 64. Germany Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 65. Germany Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 66. France Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 67. France Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 68. UK Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 69. UK Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 71. Italy Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 73. Russia Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Functional Dyspepsia Drug Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Functional Dyspepsia Drug Consumption Market Share by Application in 2019
Figure 78. Egypt Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 79. Egypt Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 81. South Africa Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 83. Israel Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 85. Turkey Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Functional Dyspepsia Drug Consumption Growth 2015-2020 (M Units)
Figure 87. GCC Countries Functional Dyspepsia Drug Value Growth 2015-2020 ($ Millions)
Figure 88. Global Functional Dyspepsia Drug Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 89. Global Functional Dyspepsia Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 91. Americas Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 92. APAC Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 93. APAC Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 94. Europe Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 95. Europe Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 97. Middle East & Africa Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 98. United States Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 99. United States Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 100. Canada Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 101. Canada Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 102. Mexico Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 103. Mexico Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 104. Brazil Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 105. Brazil Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 106. China Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 107. China Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 108. Japan Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 109. Japan Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 110. Korea Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 111. Korea Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 113. Southeast Asia Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 114. India Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 115. India Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 116. Australia Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 117. Australia Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 118. Germany Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 119. Germany Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 120. France Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 121. France Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 122. UK Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 123. UK Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 124. Italy Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 125. Italy Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 126. Russia Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 127. Russia Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 128. Spain Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 129. Spain Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 130. Egypt Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 131. Egypt Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 132. South Africa Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 133. South Africa Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 134. Israel Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 135. Israel Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 136. Turkey Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 137. Turkey Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Functional Dyspepsia Drug Consumption 2021-2025 (M Units)
Figure 139. GCC Countries Functional Dyspepsia Drug Value 2021-2025 ($ Millions)
Figure 140. Bayer Functional Dyspepsia Drug Market Share (2018-2020)
Figure 141. Eisai Functional Dyspepsia Drug Market Share (2018-2020)
Figure 142. Sumitomo Functional Dyspepsia Drug Market Share (2018-2020)
Figure 143. Teva Functional Dyspepsia Drug Market Share (2018-2020)
Figure 144. Johnson & Johnson Functional Dyspepsia Drug Market Share (2018-2020)
Figure 145. Cadila Pharmaceuticals Functional Dyspepsia Drug Market Share (2018-2020)
Figure 146. AstraZeneca Functional Dyspepsia Drug Market Share (2018-2020)
Figure 147. Pfizer Functional Dyspepsia Drug Market Share (2018-2020)
Figure 148. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Market Share (2018-2020)
Figure 149. Sanofi Functional Dyspepsia Drug Market Share (2018-2020)
Figure 150. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Market Share (2018-2020)
Figure 151. Hanmi Pharm Functional Dyspepsia Drug Market Share (2018-2020)
